" According to the latest report published by Data Bridge Market Research, the Asia-Pacific Secondary Hyperoxaluria Drug Market The Asia-Pacific secondary hyperoxaluria drug market size was valued at USD 63.8 million in 2024 and is expected to reach USD 112.10 million by 2032, at a CAGR of 7.30% during the forecast period Asia-Pacific Secondary...